Brazil Xience V Everolimus-Eluting Coronary Stent System "Real-World" Outcomes Registry
NCT00989066 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 535
Last updated 2012-11-27
Summary
To evaluate the performance and long-term clinical outcomes of the Xience V everolimus-eluting coronary stent system (EECSS) in the treatment of minimally selective, high risk patients in the real-world clinical practice.
Conditions
- Arterial Coronary Disease
Sponsors & Collaborators
-
Cardiovascular Research Center, Brazil
lead OTHER
Principal Investigators
-
Alexandre Abizaid, MD, PhD · Cardiovascular Research Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-09-30
- Primary Completion
- 2011-11-30
- Completion
- 2012-11-30
Countries
- Brazil
Study Locations
More Related Trials
-
Post-marketing Registry of Inspiron Sirolimus Eluting Coronary Stent
NCT03263260 ·Status: COMPLETED
-
The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting Stent Study in Twente
NCT01066650 ·Status: COMPLETED ·Phase: PHASE4
-
Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late Loss After Stenting
NCT00960648 ·Status: COMPLETED
-
XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)
NCT01120379 ·Status: COMPLETED
-
Zotarolimus and Everolimus-Eluting Stents ProsPectively Compared in Real World
NCT00768846 ·Status: UNKNOWN ·Phase: PHASE4
-
EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel Disease
NCT00531011 ·Status: COMPLETED ·Phase: PHASE4
-
BIOFLOW-SV Portugal Registry
NCT03600961 ·Status: TERMINATED
-
Xience/Promus for Long Coronary Lesion Registry
NCT01147237 ·Status: UNKNOWN ·Phase: PHASE4
-
BIOFLOW-SV All Comers Registry
NCT03600948 ·Status: TERMINATED
-
China Endeavor Registry: A Registry With The Endeavor Zotarolimus Eluting Coronary Stent in China
NCT00793312 ·Status: COMPLETED
-
Economic Evaluation German Drug-Eluting Stent Registry
NCT00866398 ·Status: COMPLETED
-
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)
NCT01178268 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry)
NCT01605721 ·Status: UNKNOWN ·Phase: PHASE4
-
OCT Evaluation 3 Months After Sirolimus Eluting Stent Implantation
NCT02504307 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Outcomes of EES Implantation for Unprotected Left Main Coronary Artery Stenosis (PRE-COMBAT 2)
NCT01348022 ·Status: COMPLETED
-
STENTYS Xposition S in the Treatment of Chronic Total Artery Occlusion
NCT03563989 ·Status: UNKNOWN ·Phase: NA
-
Prospective Registry of Patients Over 75 Years Old Treated With Xience Sierra Stents. Sierra 75 Study
NCT03567733 ·Status: COMPLETED
-
Registry of RESOLUTE-ONYX™ Zotarolimus-eluting Stent Utilization in Percutaneous Small Vessel Coronary Interventionism.
NCT04785846 ·Status: COMPLETED
-
Test Efficacy of Biodegradable and Permanent Limus-Eluting Stents
NCT01068106 ·Status: UNKNOWN ·Phase: PHASE4
-
XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA-Phase 1)
NCT00676520 ·Status: COMPLETED
-
A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China
NCT03736226 ·Status: ACTIVE_NOT_RECRUITING
-
Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global
NCT04236609 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Angiolite Stent vs a Second-generation Drug-eluting Stent Xience for Percutaneous Coronary Intervention
NCT03049657 ·Status: COMPLETED ·Phase: NA
-
A Trial of Bare Metal Stent - Cobalt Chromium Versus Stent Coating With Sirolimus
NCT01093391 ·Status: COMPLETED ·Phase: PHASE3
-
Everolimus-Eluting Stent for Bifurcation Coronary Lesions: Comparison of Simple Versus Complex Techniques
NCT00916695 ·Status: UNKNOWN ·Phase: PHASE4